{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:50:31Z","timestamp":1790380231642,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T00:00:00Z","timestamp":1619222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T00:00:00Z","timestamp":1619222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s40618-021-01579-4","type":"journal-article","created":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T05:05:02Z","timestamp":1619327102000},"page":"2665-2674","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Echocardiographic findings in acromegaly: prevalence of concentric left ventricular remodeling in a large single-center cohort"],"prefix":"10.1007","volume":"44","author":[{"given":"J. M.","family":"Hinojosa-Amaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. V.","family":"Varlamov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. G.","family":"Yedinak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. S.","family":"Cetas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"McCartney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Banskota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-6289","authenticated-orcid":false,"given":"M.","family":"Fleseriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,24]]},"reference":[{"issue":"1","key":"1579_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12020-014-0327-6","volume":"48","author":"J Isgaard","year":"2014","unstructured":"Isgaard J, Arcopinto M, Karason K, Cittadini A (2014) GH and the cardiovascular system: an update on a topic at heart. Endocrine 48(1):25\u201335. https:\/\/doi.org\/10.1007\/s12020-014-0327-6","journal-title":"Endocrine"},{"issue":"5","key":"1579_CR2","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1210\/edrv-15-5-555","volume":"15","author":"L Sacc\u00e0","year":"1994","unstructured":"Sacc\u00e0 L, Cittadini A, Fazio S (1994) Growth hormone and the heart. Endocr Rev 15(5):555\u2013573. https:\/\/doi.org\/10.1210\/edrv-15-5-555","journal-title":"Endocr Rev"},{"issue":"17","key":"1579_CR3","doi-asserted-by":"publisher","first-page":"8031","DOI":"10.1073\/pnas.92.17.8031","volume":"92","author":"M Buerke","year":"1995","unstructured":"Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, Lefer AM (1995) Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. PNAS 92(17):8031\u20138035. https:\/\/doi.org\/10.1073\/pnas.92.17.8031","journal-title":"PNAS"},{"issue":"3","key":"1579_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.hfc.2019.03.001","volume":"15","author":"A Colao","year":"2019","unstructured":"Colao A, Grasso LFS, Di Somma C, Pivonello R (2019) Acromegaly and heart failure. Heart Fail Clin 15(3):399\u2013408. https:\/\/doi.org\/10.1016\/j.hfc.2019.03.001","journal-title":"Heart Fail Clin"},{"issue":"8","key":"1579_CR5","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1172\/jci119730","volume":"100","author":"Q Li","year":"1997","unstructured":"Li Q, Li B, Wang X, Leri A, Jana KP, Liu Y, Kajstura J, Baserga R, Anversa P (1997) Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 100(8):1991\u20131999. https:\/\/doi.org\/10.1172\/jci119730","journal-title":"J Clin Invest"},{"issue":"1","key":"1579_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1161\/01.cir.99.1.127","volume":"99","author":"M Tajima","year":"1999","unstructured":"Tajima M, Weinberg EO, Bartunek J, Jin H, Yang R, Paoni NF, Lorell BH (1999) Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure. Circulation 99(1):127\u2013134. https:\/\/doi.org\/10.1161\/01.cir.99.1.127","journal-title":"Circulation"},{"issue":"1","key":"1579_CR7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1210\/er.2018-00115","volume":"40","author":"MR Gadelha","year":"2018","unstructured":"Gadelha MR, Kasuki L, Lim DST, Fleseriu M (2018) Systemic complications of acromegaly and the impact of the current treatment landscape: an update. Endocr Rev 40(1):268\u2013332. https:\/\/doi.org\/10.1210\/er.2018-00115","journal-title":"Endocr Rev"},{"issue":"3\u20134","key":"1579_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000095530","volume":"83","author":"G Lombardi","year":"2006","unstructured":"Lombardi G, Galdiero M, Auriemma RS, Pivonello R, Colao A (2006) Acromegaly and the cardiovascular system. Neuroendocrinology 83(3\u20134):211\u2013217. https:\/\/doi.org\/10.1159\/000095530","journal-title":"Neuroendocrinology"},{"issue":"2","key":"1579_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1046\/j.1365-2265.2003.01689.x","volume":"58","author":"A Colao","year":"2003","unstructured":"Colao A, Marzullo P, Cuocolo A, Spinelli L, Pivonello R, Bonaduce D, Salvatore M, Lombardi G (2003) Reversal of acromegalic cardiomyopathy in young but not in middle-aged patients after 12 months of treatment with the depot long-acting somatostatin analogue octreotide. Clin Endocrinol (Oxf) 58(2):169\u2013176. https:\/\/doi.org\/10.1046\/j.1365-2265.2003.01689.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"1579_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/eurheartj\/14.1.26","volume":"14","author":"S Fazio","year":"1993","unstructured":"Fazio S, Cittadini A, Sabatini D, Merola B, Colao AM, Biondi B, Lombardi G, Sacca L (1993) Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study. Eur Heart J 14(1):26\u201333. https:\/\/doi.org\/10.1093\/eurheartj\/14.1.26","journal-title":"Eur Heart J"},{"issue":"5","key":"1579_CR11","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1001\/archinte.1938.00180100014002","volume":"61","author":"C Courville","year":"1938","unstructured":"Courville C (1938) The heart in acromegaly. Arch Intern Med 61(5):704. https:\/\/doi.org\/10.1001\/archinte.1938.00180100014002","journal-title":"Arch Intern Med"},{"issue":"8","key":"1579_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1210\/jcem-2-8-477","volume":"2","author":"MB Goldberg","year":"1942","unstructured":"Goldberg MB, Lisser H (1942) Acromegaly: a consideration of its course and treatment report of four cases with autopsies. J Clin Endocrinol Metab 2(8):477\u2013501. https:\/\/doi.org\/10.1210\/jcem-2-8-477","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1579_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0002-8703(80)90277-x","volume":"100","author":"JT Lie","year":"1980","unstructured":"Lie JT, Grossman SJ (1980) Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am Heart J 100(1):41\u201352. https:\/\/doi.org\/10.1016\/0002-8703(80)90277-x","journal-title":"Am Heart J"},{"issue":"6","key":"1579_CR14","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.7326\/0003-4819-34-6-1445","volume":"34","author":"MR Hejtmancik","year":"1951","unstructured":"Hejtmancik MR, Bradfield JY Jr, Herrman GR (1951) Acromegaly and the heart: a clinical and pathologic study. Ann Intern Med 34(6):1445\u20131456","journal-title":"Ann Intern Med"},{"issue":"1","key":"1579_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1210\/jcem.85.1.6313","volume":"85","author":"S Fazio","year":"2000","unstructured":"Fazio S, Cittadini A, Biondi B, Palmieri EA, Riccio G, Bone F, Oliviero U, Sacca L (2000) Cardiovascular effects of short-term growth hormone hypersecretion. J Clin Endocrinol Metab 85(1):179\u2013182. https:\/\/doi.org\/10.1210\/jcem.85.1.6313","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1579_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1210\/jcem.85.1.6318","volume":"85","author":"A Colao","year":"2000","unstructured":"Colao A, Baldelli R, Marzullo P, Ferretti E, Ferone D, Gargiulo P, Petretta M, Tamburrano G, Lombardi G, Liuzzi A (2000) Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy. J Clin Endocrinol Metab 85(1):193\u2013199. https:\/\/doi.org\/10.1210\/jcem.85.1.6318","journal-title":"J Clin Endocrinol Metab"},{"key":"1579_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.598948","author":"X Guo","year":"2020","unstructured":"Guo X, Cao Y, Cao J, Li X, Liu P, Wang Z, Gao L, Bao X, Xing B, Wang Y (2020) Reversibility of cardiac involvement in acromegaly patients after surgery: 12-month follow-up using cardiovascular magnetic resonance. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2020.598948","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1579_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1):1-39.e14. https:\/\/doi.org\/10.1016\/j.echo.2014.10.003","journal-title":"J Am Soc Echocardiogr"},{"issue":"4","key":"1579_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","volume":"29","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, Marino P, Oh JK, Popescu BA, Waggoner AD (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29(4):277\u2013314. https:\/\/doi.org\/10.1016\/j.echo.2016.01.011","journal-title":"J Am Soc Echocardiogr"},{"issue":"11","key":"1579_CR20","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA, Endocrine S (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933\u20133951. https:\/\/doi.org\/10.1210\/jc.2014-2700","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1579_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s11102-012-0420-x","volume":"16","author":"S Melmed","year":"2013","unstructured":"Melmed S, Casanueva FF, Klibanski A, Bronstein MD, Chanson P, Lamberts SW, Strasburger CJ, Wass JAH, Giustina A (2013) A consensus on the diagnosis and treatment of acromegaly complications. Pituitary 16(3):294\u2013302. https:\/\/doi.org\/10.1007\/s11102-012-0420-x","journal-title":"Pituitary"},{"issue":"1","key":"1579_CR22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1210\/er.2002-0022","volume":"25","author":"A Colao","year":"2004","unstructured":"Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102\u2013152. https:\/\/doi.org\/10.1210\/er.2002-0022","journal-title":"Endocr Rev"},{"issue":"5","key":"1579_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1530\/eje-15-0500","volume":"173","author":"E Kuhn","year":"2015","unstructured":"Kuhn E, Maione L, Bouchachi A, Rozi\u00e8re M, Salenave S, Brailly-Tabard S, Young J, Kamenicky P, Assayag P, Chanson P (2015) Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study. Eur J Endocrinol 173(5):693\u2013702. https:\/\/doi.org\/10.1530\/eje-15-0500","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"1579_CR24","doi-asserted-by":"publisher","first-page":"4438","DOI":"10.1210\/jc.2014-2670","volume":"99","author":"M Mercado","year":"2014","unstructured":"Mercado M, Gonzalez B, Vargas G, Ramirez C, de los Monteros ALE, Sosa E, Jervis P, Roldan P, Mendoza V, L\u00f3pez-F\u00e9lix B, Guinto G (2014) Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic. J Clin Endocrinol Metab 99(12):4438\u20134446. https:\/\/doi.org\/10.1210\/jc.2014-2670","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1579_CR25","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1210\/jc.2012-3072","volume":"98","author":"AK Annamalai","year":"2013","unstructured":"Annamalai AK, Webb A, Kandasamy N, Elkhawad M, Moir S, Khan F, Maki-Petaja K, Gayton EL, Strey CH, O\u2019Toole S, Ariyaratnam S, Halsall DJ, Chaudhry AN, Berman L, Scoffings DJ, Antoun NM, Dutka DP, Wilkinson IB, Shneerson JM, Pickard JD, Simpson HL, Gurnell M (2013) A comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy. J Clin Endocrinol Metab 98(3):1040\u20131050. https:\/\/doi.org\/10.1210\/jc.2012-3072","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1579_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1365-2265.2007.03047.x","volume":"68","author":"F Bogazzi","year":"2007","unstructured":"Bogazzi F, Lombardi M, Strata E, Aquaro G, Di Bello V, Cosci C, Sardella C, Talini E, Martino E (2007) High prevalence of cardiac hypertophy without detectable signs of fibrosis in patients with untreated active acromegaly: anin vivostudy using magnetic resonance imaging. Clin Endocrinol (Oxf) 68(3):361\u2013368. https:\/\/doi.org\/10.1111\/j.1365-2265.2007.03047.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"1579_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11102-011-0318-z","volume":"15","author":"A Colao","year":"2011","unstructured":"Colao A (2011) Improvement of cardiac parameters in patients with acromegaly treated with medical therapies. Pituitary 15(1):50\u201358. https:\/\/doi.org\/10.1007\/s11102-011-0318-z","journal-title":"Pituitary"},{"issue":"5","key":"1579_CR28","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1530\/eje-11-0408","volume":"165","author":"A Colao","year":"2011","unstructured":"Colao A, Pivonello R, Grasso LFS, Auriemma RS, Galdiero M, Savastano S, Lombardi G (2011) Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study. Eur J Endocrinol 165(5):713\u2013721. https:\/\/doi.org\/10.1530\/eje-11-0408","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"1579_CR29","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/bf03344070","volume":"25","author":"G Lombardi","year":"2002","unstructured":"Lombardi G, Colao A, Marzullo P, Biondi B, Palmieri E, Fazio S (2002) Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study. J Endocrinol Invest 25(11):971\u2013976. https:\/\/doi.org\/10.1007\/bf03344070","journal-title":"J Endocrinol Invest"},{"key":"1579_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-017-0166-6","author":"JD Carmichael","year":"2017","unstructured":"Carmichael JD, Broder MS, Cherepanov D, Chang E, Mamelak A, Said Q, Neary MP, Bonert V (2017) The association between biochemical control and cardiovascular risk factors in acromegaly. BMC Endocr Disord. https:\/\/doi.org\/10.1186\/s12902-017-0166-6","journal-title":"BMC Endocr Disord"},{"key":"1579_CR31","doi-asserted-by":"publisher","first-page":"6935054","DOI":"10.1155\/2018\/6935054","volume":"2018","author":"A Popielarz-Grygalewicz","year":"2018","unstructured":"Popielarz-Grygalewicz A, G\u0105sior JS, Konwicka A, Grygalewicz P, Stelmachowska-Bana\u015b M, Zgliczy\u0144ski W, D\u0105browski M (2018) Heart in acromegaly: the echocardiographic characteristics of patients diagnosed with acromegaly in various stages of the disease. Int J Endocrinol 2018:6935054. https:\/\/doi.org\/10.1155\/2018\/6935054","journal-title":"Int J Endocrinol"},{"issue":"4","key":"1579_CR32","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11154-020-09588-z","volume":"21","author":"A Giustina","year":"2020","unstructured":"Giustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B, Boguszewski C, Bolanowski M, Bollerslev J, Bonert V, Bronstein MD, Buchfelder M, Casanueva F, Chanson P, Clemmons D, Fleseriu M, Formenti AM, Freda P, Gadelha M, Geer E, Gurnell M, Heaney AP, Ho KKY, Ioachimescu AG, Lamberts S, Laws E, Losa M, Maffei P, Mamelak A, Mercado M, Molitch M, Mortini P, Pereira AM, Petersenn S, Post K, Puig-Domingo M, Salvatori R, Samson SL, Shimon I, Strasburger C, Swearingen B, Trainer P, Vance ML, Wass J, Wierman ME, Yuen KCJ, Zatelli MC, Melmed S (2020) Multidisciplinary management of acromegaly: a consensus. Rev Endocr Metab Disord 21(4):667\u2013678. https:\/\/doi.org\/10.1007\/s11154-020-09588-z","journal-title":"Rev Endocr Metab Disord"},{"key":"1579_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-020-01091-7","author":"M Fleseriu","year":"2020","unstructured":"Fleseriu M, Biller BMK, Freda PU, Gadelha MR, Giustina A, Katznelson L, Molitch ME, Samson SL, Strasburger CJ, van der Lely AJ, Melmed S (2020) A Pituitary Society update to acromegaly management guidelines. Pituitary. https:\/\/doi.org\/10.1007\/s11102-020-01091-7","journal-title":"Pituitary"},{"issue":"1","key":"1579_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1210\/jc.2003-030849","volume":"89","author":"AM Pereira","year":"2004","unstructured":"Pereira AM, van Thiel SW, Lindner JR, Roelfsema F, van der Wall EE, Morreau H, Smit JWA, Romijn JA, Bax JJ (2004) Increased prevalence of regurgitant valvular heart disease in acromegaly. J Clin Endocrinol Metab 89(1):71\u201375. https:\/\/doi.org\/10.1210\/jc.2003-030849","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1579_CR35","doi-asserted-by":"publisher","first-page":"E1714","DOI":"10.1210\/jc.2012-1833","volume":"97","author":"L Maione","year":"2012","unstructured":"Maione L, Garcia C, Bouchachi A, Kallel N, Maison P, Salenave S, Young J, Assayag P, Chanson P (2012) No evidence of a detrimental effect of cabergoline therapy on cardiac valves in patients with acromegaly. J Clin Endocrinol Metab 97(9):E1714\u2013E1719. https:\/\/doi.org\/10.1210\/jc.2012-1833","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01579-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-021-01579-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01579-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T21:14:02Z","timestamp":1636233242000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-021-01579-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,24]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1579"],"URL":"https:\/\/doi.org\/10.1007\/s40618-021-01579-4","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,24]]},"assertion":[{"value":"29 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jos\u00e9 Miguel Hinojosa-Amaya, Elena Varlamov, Justin Cetas, Shirley McCartney, Swechya Banskota have no disclosures and no conflict of interest; Christine Yedinak disclosure\u2013consultant for\u00a0Chiasma; Maria Fleseriu disclosures\u2013principal investigator with research support to Oregon Health & Science University for clinical research studies with Novartis, Ionis, Crinetics, Chiasma and Pfizer, and she has been an occasional scientific consultant for Novartis, Ionis, Ipsen, Crinetics, Chiasma, Recordati and Pfizer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Oregon Health & Science University\u00a0institutional review board approved this human subject\u00a0research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The study was institutional review board approved with a waiver of authorization.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}